Nurix Therapeutics, Inc. NRIX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s enterprise value?
- Nurix Therapeutics, Inc. (NRIX) reported enterprise value of $1.63B in Q4 2025.
- How has Nurix Therapeutics, Inc.'s enterprise value changed year-over-year?
- Nurix Therapeutics, Inc.'s enterprise value increased by 45.1% year-over-year, from $1.12B to $1.63B.
- What is the long-term trend for Nurix Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s enterprise value has grown at a 0.7% compound annual growth rate (CAGR), from $1.55B to $1.6B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.